Neratinib in HER2 or HER3 mutant solid tumours
10 Apr 2017
Neratinib in HER2 or HER3 mutant solid tumours
Boosted radiotherapy fractions to treat rectal cancer
Editor's Choice for March 2017
Treatment of gastric cancer in Latin America
Standardised tobacco packaging in the UK
Immunotherapy for gastric cancer
Personalised therapy for gastric and pancreatic cancer
Current and future directions of immunotherapy research
Managing metastatic gastric cancer
Gastric cancer biology and aetiology
Positive impact of specialised surgery in the fight against cancer
Editor's Choice for November 2016